We focus on systemic regulation using targeted medical therapies to lower inflammatory markers, repair tissue, and restore your bodys natural ability to heal
Potential benefit - A patient whose biomarkers suggest rapid metabolism of GLP-1 drugs might be offered a longer-acting formulation, while someone with strong GIP responsiveness could start on a dual-agonist right away, avoiding months of trial-and-error
Post-meal triglycerides: Fibersol has been shown to help attenuate the rise in blood triglyerides
Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford
GLP-1 medications amplify these natural effects, and because GLP-1 receptors exist in the pancreas, liver, brain, heart, and kidneys, the benefits extend far beyond just metabolic control
They may also reduce the risk of heart disease, kidney issues, and sleep apnea